TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06299839 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06299839 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06490731 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05270213 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT05270213 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT04932512 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04932512 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05765084 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT05765084 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04611139 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT06529042 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06589830 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06638996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06058078 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06681597 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT06594848 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06710782 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06708910 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06710847 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06710223 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study NCT06733129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05889416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04956094 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT04956094 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05571527 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06272461 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04273555 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04273555 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05982197 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05982197 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04840979 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT04840979 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04761822 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06324708 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06691308 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT05231668 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05647096 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04765111 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06692959 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05271162 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT06190951 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06743035 — Surrogate Endpoint (SUR): Hematologic response
Study NCT05375747 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002407 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05941325 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05793437 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT05658003 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05658003 — Predictive Biomarker (PRD): PSMA7 mRNA
Genes: PSMA7; HSPC
Study NCT06130800 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06748053 — Predictive Biomarker (PRD): TSLP mRNA
Genes: TSLP
Study NCT05454904 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04917809 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT06016192 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05983978 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT03424473 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06440629 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06471062 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT06015919 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05748834 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05748834 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06313008 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06313008 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06493461 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05139914 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06462547 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT06462547 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study NCT05186051 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT05122377 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05122377 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05977101 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06274528 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04703218 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT05164198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05127031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05508906 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05508906 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT05508906 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04713917 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05073653 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06439693 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04978948 — Predictive Biomarker (PRD): STIM1 mRNA
Genes: STIM1; GOK
Study NCT05219721 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT05544370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06063772 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05860335 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05860335 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05860335 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05860335 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT05860335 — Predictive Biomarker (PRD): MDM4 mRNA
Genes: MDM4; MDMX
Study NCT05860335 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study NCT05860335 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT05860335 — Predictive Biomarker (PRD): FGF3 mRNA
Genes: FGF3; INT2
Study NCT05860335 — Predictive Biomarker (PRD): FGF4 mRNA
Genes: FGF4; HST; HSTF1; KS3
Study NCT05550844 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FLNA mRNA
Genes: FLNA; FLN; FLN1
Study NCT06302127 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05279014 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06512415 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05903586 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04843540 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06681467 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06680739 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04893096 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06710366 — Predictive Biomarker (PRD): AOC1 mRNA
Genes: AOC1; ABP1; DAO1
Study NCT06709586 — Surrogate Endpoint (SUR): Serum calcium
Study NCT06707493 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05488561 — Predictive Biomarker (PRD): MEFV mRNA
Genes: MEFV; MEF; TRIM20
Study NCT05983198 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05165225 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05165225 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05554939 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06055218 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06337734 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04944095 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06487078 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05843162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04623398 — Predictive Biomarker (PRD): SHANK3 mRNA
Genes: SHANK3; KIAA1650; PROSAP2; PSAP2
Study NCT04876651 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06386263 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06160076 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06310967 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05285657 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05388396 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00960921 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06166472 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT06166472 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06151431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05589272 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05293964 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05293964 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06444074 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06444074 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05995808 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05995808 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT06556719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06273631 — Predictive Biomarker (PRD): PGR mRNA
Genes: PGR; NR3C3
Study NCT04589325 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05635851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05909735 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study NCT05942053 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05942053 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06492304 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05400122 — Safety Biomarker (SAF): TGFB1
Genes: CED; TGFbeta
Study NCT04098666 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05230459 — Predictive Biomarker (PRD): FKRP mRNA
Genes: FKRP
Study NCT06039683 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06643845 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06588218 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06602063 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05324332 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04926831 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06517212 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06517212 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06517212 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06517212 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06517212 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06677866 — Predictive Biomarker (PRD): FMR1 mRNA
Genes: FMR1
Study NCT05695248 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study NCT05136690 — Pharmacodynamic Biomarker (PDY): Auditory steady-state response
Study NCT06680856 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04987931 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05009134 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06679829 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06686238 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06241456 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06241456 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05568641 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT06710717 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06710756 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06708988 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06709469 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06709469 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06709469 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT06104566 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04835064 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT06706921 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06482814 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05339126 — Predictive Biomarker (PRD): LGSN mRNA
Genes: LGSN; GLULD1; LGS
Study NCT04485130 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04485130 — Safety Biomarker (SAF): Interleukin 1
Study NCT05638503 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05973630 — Predictive Biomarker (PRD): SGCG mRNA
Genes: SGCG
Study NCT04687540 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05742074 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT05199740 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05787288 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05967000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05276284 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT06097299 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05310188 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05637671 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05637671 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05443360 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05272462 — Predictive Biomarker (PRD): ABCC8 mRNA
Genes: ABCC8; HRINS; SUR; SUR1
Study NCT06510907 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05563844 — Predictive Biomarker (PRD): HDAC1 mRNA
Genes: HDAC1; RPD3L1
Study NCT05563844 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT05563844 — Predictive Biomarker (PRD): HDAC8 mRNA
Genes: HDAC8; HDACL1; CDA07
Study NCT05563844 — Predictive Biomarker (PRD): HDAC10 mRNA
Genes: HDAC10
Study NCT05563844 — Predictive Biomarker (PRD): HDAC4 mRNA
Genes: HDAC4; KIAA0288
Study NCT05563844 — Predictive Biomarker (PRD): HDAC5 mRNA
Genes: HDAC5; KIAA0600
Study NCT05563844 — Predictive Biomarker (PRD): HDAC7 mRNA
Genes: HDAC7; HDAC7A
Study NCT05563844 — Predictive Biomarker (PRD): HDAC9 mRNA
Genes: HDAC9; HDAC7; HDAC7B; HDRP; KIAA0744; MITR
Study NCT05563844 — Predictive Biomarker (PRD): HDAC11 mRNA
Genes: HDAC11
Study NCT05839483 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06146881 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT04627571 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT05211518 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT05777746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06154187 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05005078 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT06418750 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06350773 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT06350773 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05222035 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05266014 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study NCT04962646 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04962646 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT04962646 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04962646 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06054971 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05177133 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05018676 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04520048 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04670055 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05726916 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05685836 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT05265026 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04634799 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT05361421 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05508997 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04979520 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05979480 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06019507 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT06188390 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03867851 — Predictive Biomarker (PRD): TAT mRNA
Genes: TAT
Study NCT03867851 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT06597760 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06676709 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06678698 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06686056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06710587 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT06710340 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05157672 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study NCT06039410 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05970718 — Predictive Biomarker (PRD): NPR1 mRNA
Genes: NPR1; ANPRA
Study NCT04776031 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06279195 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT06486363 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04836754 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT06351644 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06351644 — Predictive Biomarker (PRD): NUAK1 mRNA
Genes: NUAK1; ARK5; KIAA0537; OMPHK1
Study NCT04539873 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06496919 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06376981 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05783479 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01549470 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05305638 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05549219 — Predictive Biomarker (PRD): PMM2 mRNA
Genes: PMM2
Study NCT05789381 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06159543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06159543 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05420727 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06448182 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05773703 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04075136 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04075136 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06237647 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00001095 — Surrogate Endpoint (SUR): Undetectable plasma HIV RNA
Study NCT06625346 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04879277 — Surrogate Endpoint (SUR): Plasma phenylalanine
Study NCT06002243 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT06102629 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT06102629 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study NCT06102629 — Predictive Biomarker (PRD): DNMT3B mRNA
Genes: DNMT3B
Study NCT06457100 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05140590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05984771 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05984771 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05307328 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT06477640 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH